Dwight Reynolds to Heart Failure
This is a "connection" page, showing publications Dwight Reynolds has written about Heart Failure.
Connection Strength
3.028
-
Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8.
Score: 0.359
-
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. J Natl Med Assoc. 2012 May-Jun; 104(5-6):287-98.
Score: 0.330
-
The evolving challenge of chronic heart failure management: a call for a new curriculum for training heart failure specialists. J Am Coll Cardiol. 2004 Oct 06; 44(7):1354-7.
Score: 0.195
-
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol. 2014 Aug 26; 64(8):797-807.
Score: 0.097
-
Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial. Am Heart J. 2014 Apr; 167(4):429-36.
Score: 0.092
-
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014 Jan; 7(1):146-53.
Score: 0.091
-
The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jan; 25(1):43-51.
Score: 0.091
-
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
Score: 0.087
-
Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace. 2012 Oct; 14(10):1490-7.
Score: 0.083
-
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
Score: 0.083
-
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
Score: 0.081
-
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan; 163(1):49-56.e2.
Score: 0.081
-
Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012 Feb; 35(2):135-45.
Score: 0.080
-
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012 Jan-Feb; 18(1):9-17.
Score: 0.079
-
Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011 Apr 19; 123(15):1601-10.
Score: 0.077
-
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). Am J Cardiol. 2011 Jan 15; 107(2):250-8.
Score: 0.075
-
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. J Card Fail. 2010 Dec; 16(12):940-9.
Score: 0.075
-
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010 Aug 10; 122(6):585-96.
Score: 0.073
-
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
Score: 0.073
-
Electronic health records and quality of care for heart failure. Am Heart J. 2010 Apr; 159(4):635-642.e1.
Score: 0.071
-
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010 Apr 15; 105(8):1140-6.
Score: 0.071
-
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J. 2010 Feb; 159(2):238-44.
Score: 0.071
-
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010 Jan 15; 105(2):255-60.
Score: 0.070
-
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
Score: 0.070
-
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1727-34.
Score: 0.068
-
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009 Apr; 157(4):754-62.e2.
Score: 0.067
-
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm. 2008 Jun; 5(6):907-25.
Score: 0.063
-
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008 Jul; 1(2):98-106.
Score: 0.063
-
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007 Jul; 154(1):12-38.
Score: 0.059
-
Implant experience with an implantable hemodynamic monitor for the management of symptomatic heart failure. Pacing Clin Electrophysiol. 2005 Aug; 28(8):747-53.
Score: 0.052
-
Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003 Feb 19; 41(4):565-71.
Score: 0.044
-
Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002 Apr; 8(2):63-70.
Score: 0.041
-
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol. 2010 Jun 15; 105(12):1773-9.
Score: 0.018